Blar i Working papers (SNF) på forfatter "Brekke, Kurt Richard"

Viser treff 1-6 av 6

    • Direct to consumer advertising in pharmaceutical markets 

      Brekke, Kurt Richard; Kuhn, Michael (Working paper, Working paper, 2005-02)
      We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptability ...

    • Margins and market shares : pharmacy incentives for generic substitution 

      Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune (Working paper;08/13, Working paper, 2013-02)
      We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to ...

    • Pharmaceutical patents : incentives for R&D or marketing? 

      Brekke, Kurt Richard; Straume, Odd Rune (Working paper, Working paper, 2005-11)
      We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future ...

    • Quality and location choices under price regulation 

      Brekke, Kurt Richard; Nuscheler, Robert; Straume, Odd Rune (Working Paper, Working paper, 2002-12)
      In a model of spatial competition, we analyse the equilibrium outcomes in markets where the product price is exogenous. Using an extended version of the Hotelling model, we assume that firms choose their locations and the ...

    • Quality competition with profit constraints 

      Brekke, Kurt Richard; Siciliani, Luigi; Straume, Odd Rune (Working paper;30/12, Working paper, 2012-09)
      Firms in markets such as health care and education are often profit constrained due to regulation or their non-profit status, and they are often viewed as being altruistic towards consumers. We use a spatial competition ...

    • Regulation and pricing of pharmaceuticals : reference pricing or price cap regulation? 

      Brekke, Kurt Richard; Grasdal, Astrid Louise; Holmås, Tor Helge (Working paper, Working paper, 2006-11)
      We study the relationship between regulatory regimes and pharmaceutical firms pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” ...